MX2022015141A - Composiciones y metodos de uso de un compuesto de control de inapetencia. - Google Patents
Composiciones y metodos de uso de un compuesto de control de inapetencia.Info
- Publication number
- MX2022015141A MX2022015141A MX2022015141A MX2022015141A MX2022015141A MX 2022015141 A MX2022015141 A MX 2022015141A MX 2022015141 A MX2022015141 A MX 2022015141A MX 2022015141 A MX2022015141 A MX 2022015141A MX 2022015141 A MX2022015141 A MX 2022015141A
- Authority
- MX
- Mexico
- Prior art keywords
- inappetance
- livestock
- compositions
- methods
- controlling compound
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000001875 compounds Chemical class 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 3
- 244000144972 livestock Species 0.000 abstract 3
- KVLLHLWBPNCVNR-SKCUWOTOSA-N capromorelin Chemical compound C([C@@]12CN(CCC1=NN(C2=O)C)C(=O)[C@@H](COCC=1C=CC=CC=1)NC(=O)C(C)(C)N)C1=CC=CC=C1 KVLLHLWBPNCVNR-SKCUWOTOSA-N 0.000 abstract 2
- 229950004826 capromorelin Drugs 0.000 abstract 2
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 abstract 1
- 235000013355 food flavoring agent Nutrition 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/132—Heterocyclic compounds containing only one nitrogen as hetero atom
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/111—Aromatic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/116—Heterocyclic compounds
- A23K20/137—Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Food Science & Technology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Fodder In General (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Feed For Specific Animals (AREA)
- Dermatology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
La invención proporciona un método para tratar la pérdida de peso inducida por inapetencia en uno o varios animales de compañía o ganado. El método proporciona la administración de una cantidad terapéuticamente eficaz de una composición que contiene capromorelina al animal de compañía o ganado. Opcionalmente, uno o varios agentes aromáticos o agentes que enmascaran el sabor se pueden añadir a la composición que contiene capromorelina para realzar o enmascarar el condimento de la composición para el animal de compañía o ganado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261706164P | 2012-09-27 | 2012-09-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022015141A true MX2022015141A (es) | 2023-02-01 |
Family
ID=50339468
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015003564A MX2015003564A (es) | 2012-09-27 | 2013-09-27 | Composiciones y metodos de uso de un compuesto de control de inapetencia. |
| MX2022015141A MX2022015141A (es) | 2012-09-27 | 2015-03-19 | Composiciones y metodos de uso de un compuesto de control de inapetencia. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2015003564A MX2015003564A (es) | 2012-09-27 | 2013-09-27 | Composiciones y metodos de uso de un compuesto de control de inapetencia. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US11090292B2 (es) |
| EP (3) | EP3524260B1 (es) |
| JP (2) | JP6779618B2 (es) |
| KR (5) | KR20190143484A (es) |
| CN (2) | CN111419845A (es) |
| AR (2) | AR092713A1 (es) |
| AU (2) | AU2013323349B2 (es) |
| BR (1) | BR112015006282B1 (es) |
| CA (1) | CA2886091C (es) |
| DK (1) | DK3524260T3 (es) |
| ES (1) | ES2959427T3 (es) |
| MX (2) | MX2015003564A (es) |
| NZ (2) | NZ746394A (es) |
| PL (1) | PL3524260T3 (es) |
| PT (1) | PT3524260T (es) |
| RU (1) | RU2648958C2 (es) |
| TW (3) | TWI732158B (es) |
| WO (1) | WO2014052780A2 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011105611A1 (ja) | 2010-02-26 | 2011-09-01 | ラクオリア創薬株式会社 | 悪液質を治療するためのグレリン受容体作動物質 |
| WO2013119800A1 (en) | 2012-02-07 | 2013-08-15 | Massachusetts Institute Of Technology | Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness |
| NZ746394A (en) | 2012-09-27 | 2019-01-25 | Aratana Therapeutics Inc | Compositions and methods of use of an inappetance-controlling compound |
| WO2014144231A1 (en) | 2013-03-15 | 2014-09-18 | Massachusetts Institute Of Technology | Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness |
| KR20180108916A (ko) * | 2015-01-28 | 2018-10-04 | 아라타나 세라퓨틱스, 인크. | 체중-증량 화합물의 장기 사용을 위한 조성물 및 방법 |
| WO2016138099A1 (en) | 2015-02-24 | 2016-09-01 | Massachusetts Institute Of Technology | Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness |
| US20190269152A1 (en) * | 2016-11-11 | 2019-09-05 | Hill's Pet Nutrition, Inc. | Compositions and Methods of Pet Food |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US193273A (en) * | 1877-07-17 | Improvement in material for pulley-covers | ||
| JP2893901B2 (ja) * | 1990-09-07 | 1999-05-24 | 株式会社岐阜免疫研究所 | 動物用抗体含有油性ペースト製剤 |
| CA2095786A1 (en) | 1992-05-08 | 1993-11-09 | Franco J. Vaccarino | Method of stimulating appetite |
| TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
| ES2333097T3 (es) | 2000-05-31 | 2010-02-17 | Raqualia Pharma Inc | Uso de secretagogos de la hormona de crecimiento para estimular la motilidad gastrointestinal. |
| EP1181933A3 (en) * | 2000-06-29 | 2002-04-10 | Pfizer Products Inc. | Use of growth hormone secretagogues for stimulating or increasing appetite |
| US8309603B2 (en) | 2004-06-07 | 2012-11-13 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US7491695B2 (en) * | 2003-06-18 | 2009-02-17 | Tranzyme Pharma Inc. | Methods of using macrocyclic modulators of the ghrelin receptor |
| US7476653B2 (en) * | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
| EP1742655A2 (en) * | 2004-04-07 | 2007-01-17 | Gastrotech Pharma A/S | Use of ghrelin for the treatment of hyperthyroidism |
| EP1812045A2 (en) * | 2004-10-27 | 2007-08-01 | Gastrotech Pharma A/S | Uses of secretagogues for treatment of organ transplant patients |
| BRPI0618222A2 (pt) * | 2005-11-02 | 2011-08-23 | Nestec Sa | composições de isoflavona para reduzir o acúmulo de gordura corporal em animais machos, e métodos para seu uso |
| WO2007108990A2 (en) * | 2006-03-13 | 2007-09-27 | Liat Mintz | Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite stimulation |
| BRPI0717169C1 (pt) * | 2006-09-27 | 2012-12-04 | Ipsen Pharma Sas | análogos de grelina substituìda no n-terminal |
| JP2008127377A (ja) * | 2006-11-24 | 2008-06-05 | Jichi Medical Univ | Ｇｈｓ−ｒ作動薬を含有してなるメタボリックシンドローム又は高血圧症の予防・治療剤。 |
| US20080226802A1 (en) * | 2007-03-14 | 2008-09-18 | Concentrate Manufacturing Company Of Ireland | Beverage having natural sweeteners with one or more stevia components and source of berry |
| TWI429436B (zh) | 2007-04-10 | 2014-03-11 | Helsinn Therapeutics Us Inc | 使用生長激素促泌素治療或預防嘔吐之方法 |
| RU2007129408A (ru) * | 2007-07-31 | 2009-02-10 | Игорь Николаевич Жирков (RU) | Способ выращивания поросят в период откорма |
| FR2920295B1 (fr) | 2007-09-05 | 2009-12-11 | Desvac | Dispositif d'injection de produits veterinaires a des volailles, comprenant un element de contention presentant une forme anatomique incluant des moyens de calage d'un os reperable |
| CN101854814B (zh) * | 2007-11-12 | 2013-07-31 | 三荣源有限公司 | 改善甜叶菊提取物甜味的方法 |
| MA33214B1 (fr) * | 2009-03-26 | 2012-04-02 | Takeda Pharmaceutical | Compose pyrazole |
| WO2011105611A1 (ja) | 2010-02-26 | 2011-09-01 | ラクオリア創薬株式会社 | 悪液質を治療するためのグレリン受容体作動物質 |
| NZ746394A (en) | 2012-09-27 | 2019-01-25 | Aratana Therapeutics Inc | Compositions and methods of use of an inappetance-controlling compound |
-
2013
- 2013-09-27 NZ NZ746394A patent/NZ746394A/en unknown
- 2013-09-27 KR KR1020197037811A patent/KR20190143484A/ko active Application Filing
- 2013-09-27 KR KR1020237019962A patent/KR20230097201A/ko not_active Application Discontinuation
- 2013-09-27 CA CA2886091A patent/CA2886091C/en active Active
- 2013-09-27 RU RU2015114996A patent/RU2648958C2/ru active
- 2013-09-27 KR KR1020157009647A patent/KR20150058345A/ko not_active IP Right Cessation
- 2013-09-27 BR BR112015006282-2A patent/BR112015006282B1/pt active IP Right Grant
- 2013-09-27 ES ES19161662T patent/ES2959427T3/es active Active
- 2013-09-27 CN CN202010001164.1A patent/CN111419845A/zh active Pending
- 2013-09-27 DK DK19161662.2T patent/DK3524260T3/da active
- 2013-09-27 US US14/039,114 patent/US11090292B2/en active Active
- 2013-09-27 EP EP19161662.2A patent/EP3524260B1/en active Active
- 2013-09-27 AU AU2013323349A patent/AU2013323349B2/en active Active
- 2013-09-27 NZ NZ707174A patent/NZ707174A/en active IP Right Revival
- 2013-09-27 PL PL19161662.2T patent/PL3524260T3/pl unknown
- 2013-09-27 EP EP13841455.2A patent/EP2906041A4/en not_active Withdrawn
- 2013-09-27 WO PCT/US2013/062227 patent/WO2014052780A2/en active Application Filing
- 2013-09-27 CN CN201380061931.6A patent/CN105072909A/zh active Pending
- 2013-09-27 TW TW107142255A patent/TWI732158B/zh active
- 2013-09-27 TW TW109121986A patent/TW202106298A/zh unknown
- 2013-09-27 JP JP2015534747A patent/JP6779618B2/ja active Active
- 2013-09-27 TW TW102135177A patent/TWI667024B/zh active
- 2013-09-27 MX MX2015003564A patent/MX2015003564A/es active IP Right Grant
- 2013-09-27 AR ARP130103486A patent/AR092713A1/es not_active Application Discontinuation
- 2013-09-27 PT PT191616622T patent/PT3524260T/pt unknown
- 2013-09-27 EP EP23191187.6A patent/EP4302825A2/en active Pending
- 2013-09-27 KR KR1020217001509A patent/KR20210009438A/ko not_active Application Discontinuation
- 2013-09-27 KR KR1020217042990A patent/KR20220003640A/ko not_active IP Right Cessation
-
2015
- 2015-03-19 MX MX2022015141A patent/MX2022015141A/es unknown
-
2016
- 2016-08-22 AU AU2016216741A patent/AU2016216741B2/en active Active
-
2018
- 2018-03-07 JP JP2018041063A patent/JP6796097B2/ja active Active
-
2021
- 2021-10-22 AR ARP210102942A patent/AR123902A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2022015141A (es) | Composiciones y metodos de uso de un compuesto de control de inapetencia. | |
| MX2021015234A (es) | Composiciones y metodos que comprenden bupropion o compuestos relacionados y dextrometorfano. | |
| PH12016500511A1 (en) | Selective grp94 inhibitors and uses thereof | |
| PH12017500070A1 (en) | Methods of treating cancer using tigit inhibitors and anti-cancer agents | |
| EA201500923A1 (ru) | Замещенные (бензилцианометил)амиды 2-азабицикло[2.2.1]гептан-3-карбоновых кислот в качестве ингибиторов катепсина с | |
| EA201290919A1 (ru) | Индазольные соединения и их применение | |
| MX344238B (es) | Compuestos de tetrazol y métodos para preparar y usar los mismos. | |
| EA201590880A1 (ru) | Композиции и способы лечения протеинопатий | |
| NZ708453A (en) | Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants | |
| PH12014502864A1 (en) | Pharmaceutical compositions and treatment of mastitis | |
| EA201692481A1 (ru) | Комбинация, содержащая глюкокортикоид и edo-s101 | |
| NZ706990A (en) | A veterinary method of alleviating noise aversion | |
| MX2019006773A (es) | Dexmedetomidina o medetomidina para uso en el tratamiento de la ansiedad por separacion en perros. | |
| EA201591507A1 (ru) | Лечение рассеянного склероза лахинимодом | |
| MX2020001428A (es) | Composiciones de grapiprant y metodos para usar las mismas. | |
| MX2015005734A (es) | Metodos de tratamiento de enfermedades hepaticas. | |
| MX2013013098A (es) | Metodos y composiciones para fomentar el crecimiento de la masa corporal magra. | |
| NZ733658A (en) | Compositions and methods for chronic use of a weight-gaining compound | |
| MX2017007856A (es) | Composicion para el cuidado bucal. | |
| MY197404A (en) | Benzoic acid or a salt and derivative thereof for use in preventing or treating depression | |
| IN2015DN00735A (es) | ||
| MX2014008194A (es) | Cefovecina util en el tratamiento de la enfermedad de lyme. | |
| MX2013012990A (es) | Metodos y composiciones para preservar la masa corporal magra durante la perdida de peso. | |
| NZ701190A (en) | Combination meloxicam and xylazine therapy in animals |